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Case Report

Germ cell tumor and Takotsubo Cardiomyopathy:
A treatment dilemma
Abdul Hannan1, Muhammad Faisal Khalid2, Samia Yasmeen3
ABSTRACT
Germ cell tumors (GCT) are uncommon malignancies in adult males and comprise less than 1% of male
cancers. Due to highly curative nature and productive life years gained after treatment; reduction of
chemotherapy related toxicities becomes vital. Cisplatin is the backbone of GCT chemotherapy, & is related
to myocardial injury, thromboembolism & vasculitis. Though it should not be replaced with Carboplatin,
however in certain circumstances, its use maybe unsafe; especially in cases when patient have prior
myocardial infarction. We report a case of Takotsubo cardiomyopathy (TCM)secondary to GCT diagnosis in a
young male. This patient presented withsymptoms of myocardial infarction however, coronary angiography
was normal and a diagnosis of TCM was made. Though, it is rare but a unique challenge, as whether
Cisplatin use would be safe in this particular scenario? On one hand patient had stress related myocardial
injurywhile he was also at risk of further Cisplatin induced complications.There are no clear cut guidelines,
so after informed consent his treatment regimen was modified to EC (Etoposide/Carboplatin) instead of
EP (Etoposide/Cisplatin). Patient has completed 4.6 years of follow-up without any evidence of relapse.
We suggest informed decisions and to weigh the pros and cons of using an inferior regimen, in order
to achieve same long term prognosis while preventing any acute complications,in younger patients with
curable cancers.
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INTRODUCTION
Germ cell tumors (GCT) are a classic example
of cure among solid malignancies. Cure has been
achieved in almost 80% of cases with 5-year
survival rates of more than 95% in developed
countries.1 Reducing the treatment related toxicities
becomes more important with high cure rates. Off
note, Cisplatin is an integral component of GCT
chemotherapy & it can’t be replaced with any other
agents like carboplatin, as direct comparisons have
consistently showed inferior outcomes.2,3 However,
sometimes there are unique treatment challenges
in cases where use of Cisplatin may be related to
poor outcomes or complications like vasculitis.
Here we report a patient with newly diagnosed
GCT, who developed Takatsubo Cardiomyopathy
(TCM) due to stress of cancer diagnosis and had
a compelling indication to change the treatment
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regimen. Though not the standard of cure with
very limited data available for use of Carboplatin,
keeping the balance in side effects and long term
prognosis is important in treatment of highly
curable malignancies, especially in young patients,
which is highlighted in this case report.
CASE REPORT
A 32 years old male presented with painless and
gradually enlarging right testicular swelling of 3
months duration.Right inguinal orchiectomy was
performed and 3 weeks post Op B-hCG was 2900IU,
AFP was 890 ng/ml while LDH was 560mg/ml.
Histopathology showed yolk sac tumor (65%),
immature teratoma (20%) and seminoma (15%).
Baseline CT scan showed a 1.8cm right para-aortic
lymph nodewith no other metastatic disease. Patient
was staged as Stage IIA-S1, Good risk Mixed Germ
Cell Tumor (MGCT) depending upon the markers&
CT findings. Chemotherapy was planned within 3
weeks of surgery; however patient presented after
2nd week of orchiectomy to ER with severe chest pain.
At presentation, cardiac enzymes were elevated
and his Trop-I was 6.2 (normal < 0.4), while EKG
showed 1.8mm ST segment elevation in leads V1V3. Cardiology team was consulted immediately
& echocardiogram was performed which showed
apical hypokinesis with EF of 49%. His cardiac
catheterization was reported to be normal with
normal coronaries and without any flow restriction
(Fig.1). Depending upon the presentation, EKG

changes, elevated Trop-Iwith absence of any flow
restriction and normal coronary angiogram, TCM
diagnosis was established, based upon Mayo clinic
diagnostic criteria (Table-I).4 Patient was started on
angiotensin converting enzyme inhibitors and betablockers,and his chemotherapy was delayed by 3
weeks.
Later his chemotherapy regimen was modified
to EC x 4 (Etoposide 100 mg/m2IV Day 1-5 /
Carboplatin AUC-5 IV Day 1 only) instead of EP
(Etoposide / Cisplatin). Though there is scarce
data regarding the use of Carboplatin in MGCT
and Cisplatin has been shown to be superior to
Carboplatin, however due to a risk of Cisplatin
induced vasculitis or acute thrombosis, the
treatment regimen was modified with informed
consent. Patient was treated with 4 cycles of EC
and after 2nd cycle his markers normalized. At
this time decision was reviewed to cut down his
chemotherapy to only 3 cycles of EC but it was
considered that he is already getting sub-optimal
regimen, so he was continued with complete 4
cycles. He tolerated his treatment well,achieved
complete biochemical and radiological response
and placed on surveillance. Patient has completed
4.6 years of follow-up according to National
Comprehensive Cancer Network guidelines and
remains well without any evidence of relapse. After
6 months of his treatment with ACEi and BBs, both
were also stopped as he had normal EF (62%) on
echocardiogram.

Fig.1: Cardiac Catheterization images showing normal diastolic left ventricular cavity (Left)
and anterior and apical ballooning during systole.
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Table-I: Mayo clinic Diagnostic Criteria for Takotsubo cardiomyopathy.4
1.
2.
3.
4.

Suspected acute MI based on symptoms, ECG changes, &/or elevation of cardiac enzymes
Transient LV wall motion abnormalities extending beyond a single epicardial vascular distribution.
Absence of potentially culpritcoronary stenosis by angiography (≤ 50%) luminal narrowing of the epicardial
arteries and no angiographic evidence of acute plaque rupture.
No clinical indicator of myocarditis or pheochromocytoma.

DISCUSSION
Takotsubo cardiomyopathy (TCM), also known
as “stress cardiomyopathy” or “broken heart
syndrome” was first described in Japan in 1990 by
Sato et al. with increased recognition throughout
the world thereafter.5 TCM is a transient reversible
left ventricular systolic dysfunction associated with
stress, mimicking ST segment elevation myocardial
infarctionon electrocardiography.5 It has been
reported in 1-2% of patients who present with
troponin positive acute coronary syndrome.6
Studies have reported a higher incidence of
TCM among cancer patients (10%), with different
types of cancers, chemotherapeutic agents, tyrosine
kinase inhibitors & monoclonal antibodies.7 The
relationship between Takotsubo cardiomyopathy,
malignancy diagnosis & chemotherapy remains
mysterious. Adrenergic excess, coronary artery
vasospasm & microvascular dysfunction have
been reported as possible mechanisms.8 Studies
have suggested that cancer can lower the
threshold for stress stimuli and may aggravate
cardiac adrenoreceptor sensitivity predisposing
patients to develop TCM. Among all the proposed
mechanisms, adrenergic surge due to stress is most
plausible as diagnosis of cancer is a significant
stressor, leading to coronary micro-vascular spasm
resulting in myocardial infarction.9 However,
why it only involves apical or anterior segment, is
unknown. The other postulated explanation is as
part of cancer-related paraneoplastic syndrome,
which remains to be further elucidated.
Our case is unique as it was not related to
chemotherapy, rather TCM happened due to
stress of cancer diagnosis before chemotherapy
treatment& led us to modify the treatment regimen.
The standard of care for Stage IIA - Good risk
MGCTis either four cycles of EP regimen (Etoposide
100mg/m2, Cisplatin 20 mg/m2) or three cycles
of BEP regimen (Bleomycin 30 units every week,
Etoposide 100mg/m2, Cisplatin 20 mg/m2), every
three weeks.10 We usually use EP regimen to avoid
Bleomycin pulmonary toxicity as an institutional
practice, moreover in our patient there was
baseline dyspnea secondary to his recent TCM,
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which precluded Bleomycin use.Though Cisplatin
remains the cornerstone of GCT chemotherapy
and a standard of care, however it is also related
to some other rare side effects like vasculitis,
cardiomyopathy and vascular thrombosis. Various
different mechanisms has been mentioned for
cisplatin induced cardiomyopathy and thromboembolism, some of which are endovascular injury
with intimal fibrosis, decreased activation of
protein C, hypomagnesaemia and myocardial fiber
apoptosis.11 Due to potential risk of further cardiac
complications, it was a treatment challenge as to
whether we should use Cisplatin or not, in a patient
with a new cardiac event as TCM.
Bajorin DF et al. randomized 270 patients with
Good risk GCT to receive either four cycles of
EP or EC and showed that the relapse rates were
significantly higher (24%) in EC arm, as compared
to EP arm (13%).2 They also reported inferior event
free and relapse free survival for EC arm, however no
difference in overall survival was noted. Similarly,
Horwich A et al. reported inferior outcomes when
they randomized 598 patients with good risk MGCT
to either receive BEP or BEC, replacing Cisplatin
for Carboplatin.3 They concluded that combination
chemotherapy with Carboplatin containing
regimens is inferior to Cisplatin regimens, and
reported 3 year survival rates of 90% as compared
to 97%. Though there are no reports or robust
data for the use Carboplatinin MGCT patients at
increased risk of cardiac complications, however
modification of treatment regimen may be needed
in special scenarios like the case we report. To the
best of our knowledge, this is the first documented
report of TCM with significant implication on his
treatment requiring chemotherapeutic regimen
change.
This case highlights the importance of considering
alternate chemotherapeutic agents in patients who
are at risk of future cardiovascular events or who
have prior myocardial injury. Though Cisplatin
containing regimens remain the standard of care
in MGCT, Carboplatin may be used and a fair
option in special scenarios likes the reported
case. We recommend informed discussion before
substituting Cisplatin with Carboplatin, especially
Vol. 34 No. 4
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in younger patients with curable malignancies, in
whom careful balance between risks of immediate
cardiac side effects with Cisplatin versus slightly
compromised long term survival with Carboplatinis
of paramount importance.
Grant Support & Financial Disclosures: None.
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What is a university education?
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What are three functions of a university? These
are knowledge production, dissemination and
application through the means of research, learning
and public service. The solid base of undergraduate
education forms the foundation for research and
graduate education at the university level. The
research based education does not discriminate
research from teaching. It is rather an integral
part of knowledge production and dissemination
through the scientific spirit. It is the driving spirit
of objective inquiry. It is required throughout
the entire educational process. It is a crucial part
of quality education as well as indispensible
factor for the evolution of modern scientific and
universal cultural climate. Therefore, the scientific
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spirit should be treated as the creative energy for
education at every step of educational process.
Since science deals with the relative truth, the
established working model of a mechanism can be
challenged and replaced by new ones. In this way
science has become the lighthouse of progress for
the human race. Since science deals with the testing
of imagination by experimentation, the dearest
imagination can stand against bitter data to test the
critical thinking and the intellectual honesty. It may
be inferred that research based education nurtures
the scientific spirit as the fuel for the lighthouse
that should never dim. To promote scientific spirit
driven research should thus be the ultimate goal
of a university enabling the critical experimental
intellect of mentors and mentees to drive the
generation cycle of an institution.
Professor HR Ahmad
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Aga Khan University,
Karachi 74800, Pakistan.
Vol. 34 No. 4

www.pjms.com.pk

1033

